Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
The objectives of the study are: to research the association, if any, between the occurrence of thyroid function changes in the immediate post-transplant period and the prognosis of the transplant itself; identify any risk factors for the occurrence of thyroid disorders In the immediate post-transplant period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects transplanted at our Center;
Subjects whose 3-month follow-up is available;
Age ≥18 years;
Availability of clinical and laboratory data regarding thyroid function trends in the immediate post-transplant period (within 30 days after transplantation);
Disqualifiers
None.
Trial population
All kidney transplant patients at the U.O. of Nephrology, Dialysis and Transplantation directed by Prof. Gaetano La Manna of Policlinico Sant'Orsola - IRCCS Azienda Ospedaliero Universitaria di Bologna.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Kidney transplant patients
Trial outcomes
Primary outcomes
1
Thyroid function
To research, if any, the alteration of thyroid function in the immediate post-transplant period
Time frame
At baseline, then 3-month follow-up after kidney transplantation2
Renal function
Investigating renal function three months after transplantation.
Time frame
At 3-month follow-up after kidney transplantation3
Medical complications
Investigate about medical complications in the post-transplant period
Time frame
Baseline (surgery), at 3-month follow-up after kidney transplantation, at patient discharge4
Survival
Patient survival at three months after transplantation.
Time frame
At 3-month follow-up after kidney transplantationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov